| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.6M | +17.0% |
| Cost of Revenue | $8.1M | +14.0% |
| Gross Profit | $8.5M | +20.0% |
| R&D Expense | $43.9M | -13.3% |
| SG&A Expense | $42.6M | -24.7% |
| Operating Income | -$78.0M | +22.1% |
| Pre-tax Income | -$73.4M | +15.1% |
| Income Tax | $201K | +105.1% |
| Net Income | -$73.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.3M | +16.0% |
| Inventory | $7.8M | +4.8% |
| Current Assets | $201.5M | -20.4% |
| Total Assets | $296.1M | -19.2% |
| Current Liabilities | $15.7M | +2.4% |
| Total Liabilities | $36.8M | -5.8% |
| Stockholders' Equity | $259.3M | -20.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.4M | +3.6% |
| Capital Expenditures | $1.8M | -49.9% |
| Investing Cash Flow | $61.5M | -6.5% |
| Financing Cash Flow | -$10.6M | +8.1% |
| Free Cash Flow | -$46.2M | +6.9% |
| +15.0% |